Listen to the replay of the IMF Patient & Family Webinar. This features a panel discussion about the latest updates on frontline therapy for myeloma patients led by IMF Chairman Dr. Brian G.M. Durie.

Panelists include Dr. Rafat Abonour of Indiana University, Dr. Paul G. Richardson of the Dana Farber Cancer Institute, and Patient Advocate Yelak Biru.

This webinar includes the following topics of discussion:

• COVID-19 (coronavirus) (https://www.myeloma.org/videos/coronavirus-covid-19-multiple-myeloma): What are the symptoms? How to avoid exposure?
• Frontline Therapy (https://www.myeloma.org/videos/frontline-therapy-multiple-myeloma): Are triplet regimens the way forward?
• Maintenance (https://www.myeloma.org/videos/maintenance-multiple-myeloma-patients): What are the recommendations for maintenance therapy?
• Approaches to Relapse (https://www.myeloma.org/videos/approaches-relapse-multiple-myeloma-patients): What are current relapse options?
• Novel Therapies (https://www.myeloma.org/videos/novel-therapies-multiple-myeloma-patients): What can be expected in 2020?

Download Slides (https://s3.us-west-1.wasabisys.com/imf-d8-prod/2020-03/PFS_Webinar_March142020.pdf)

Myeloma Terms & Definitions (https://s3.us-west-1.wasabisys.com/imf-d8-prod/resource/glossary_0.pdf)   Myeloma Acronyms (https://s3.us-west-1.wasabisys.com/imf-d8-prod/resource/Acronyms.pdf)

If you have any questions, please contact:

The International Myeloma Foundation
1-800-452-CURE (2873)
[email protected] (mailto:[email protected]?subject=Boca%20PFS%202018)

with support from:
Amgen, The Binding Site, Bristol-Myers Squibb, Genentech, GSK, Janssen Oncology, Karyopharm Therapeutics, Takeda Oncology